Home /bio Based Commercialization Strategy Impact Story Bio-based Commercialization Strategy: How we worked with a petrochemical leader to deliver the commercial due diligence necessary for a Go or No-Go investment decision

At-a-glance

A leading petrochemical company is exploring bio-based alternatives to synthetic chemicals used in cosmetics and needed clarity on market potential, demand drivers, key success factors and feedstock availability before committing to large-scale investment.

Through a structured assessment of markets, customers, competitors, regulations, and feedstock sourcing, we identified which products merited investment, highlighted price sensitivity challenges, and informed their future market entry strategy.

Your analysis gave us the confidence to focus on the right bio-based chemicals and avoid costly missteps.

The Challenge

The client wanted to shift from petrochemical to bio-based cosmetic ingredients but lacked insight into market viability, pricing acceptance, and supply feasibility.

Unclear Market Demand

Limited visibility on customer willingness to adopt bio-based alternatives across regions.

Price Premium Uncertainty

Unsure if brands or consumers would accept higher costs compared to synthetics.

Feedstock Sourcing Risks

Uncertainty on reliable feedstock supply and cost dynamics across geographies.

Competitive Landscape Gaps

Incomplete view of existing bio-alternative players and their positioning.


The Solution

We delivered a multi-layered market, customer, and feedstock analysis to enable informed Go/No-Go decisions.

Stage 1 Stage 2 Stage 3 Stage 4
Market Assessment Customer Insights Competitive Benchmarking Feedstock Evaluation
Sized the market by volume and value, segmented by geography, and identified growth drivers and regulatory factors. Engaged beauty and personal care manufacturers to understand switching potential, price thresholds, and demand trends. Mapped competitors across key regions to reveal positioning and differentiation opportunities. Assessed raw material availability, cost outlook, and future supply risks to guide plant location decisions.

The Findings

Our benchmarking uncovered unexpected dynamics across competitor strategies, pricing, and portfolios. These insights gave the client a clear view of their own position and where they were falling behind.

FutureBridge_ Findings     Findings   FutureBridge_What It Meant  What It Meant
No regulatory driver for bio-based adoption in cosmetics Transition to bio-based chemicals is predominately brand and consumer led which underpins slow adoption rate and making market positioning critical.
Notable challenge regarding willingness-to-pay The bio-based chemicals being assessed (direct replacements for synthetics) cost notably more than the 5–10% premium customers are willing to pay which limits markets to premium brands
Market potential concentrated in premium brands US and European premium beauty segments show the strongest willingness to adopt bio-based ingredients while uptake in other markets was found to be minimal.

The Impact

The client received a clear pre-investment roadmap identifying which bio-based products merited further development and which to deprioritize. This informed their next phase of scale-up plant investment and market entry planning.

Go/No-Go Clarity Pricing Strategy Focus Future Market Entry Plan Pipeline Prioritization
One compound deprioritized, one advanced for commercialization planning. Triggered a deep-dive study on acceptable price points to bridge cost gaps. Laid foundation for targeted market entry and feedstock sourcing strategies. Framework established to assess more than 30 additional bio-based products in development.

Want to explore your sustainable alternatives in your chemical portfolio? Contact us to identify, shortlist, and recommend.

Need a thought partner?

Share your focus area or question to engage with our Analysts through the Business Objectives service.

Submit My Business Objective

Our Clients

Our long-standing clients include some of the worlds leading brands and forward-thinking corporations.